Condensed Interim Consolidated Statements of Operations - CAD ($) $ in Thousands	3 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Operating expenses
Research and development	$ 297	$ 145
General and administrative	2,408	235
Total operating expenses	2,705	380
Loss from operations	(2,705)	(380)
Other expenses (income)	29	(2)
Interest expenses (income), net	(11)	38
Warrant expense (income)	5
Change in fair value of Forward Purchase Agreement	183
Total other expenses	206	36
Loss before income taxes	(2,911)	(416)
Income tax expense
Net Loss	$ (2,911)	$ (416)
Basic weighted average Common shares outstanding (in Shares)	19,246,089	5,075,420
Diluted weighted average Common shares outstanding (in Shares)	19,246,089	5,075,420
Basic net loss per share, Common shares (in Dollars per share)	$ (0.15)	$ (0.08)
Diluted net loss per share, Common shares (in Dollars per share)	$ (0.15)	$ (0.08)